Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic


- Up to 200 subjects will receive four curated strains never before given in combination as a synbiotic treatment, as part of a development plan to improve infant health outcomes - - Up to 200 subjects will receive four curated strains never before given in combination as a synbiotic treatment, as part of a development plan to improve infant health outcomes -

See the article here:
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic

Related Posts